0.25
-1.76%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Amoeba
Its shares trade on Euronext Paris under the ticker ALMIB.PA. It has been listed since 10 July 2015. In the fiscal year to 31 December 2019, it reported revenue of €120,000 and a net loss of €7.3m. At that date it held total assets of €13.9m and shareholders' equity of €4.3m.
Amoéba SA engages in developing, manufacturing and biological products. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 10 Jul 2015
- Employees
- 15
- Website
- amoeba-biocide.com/fr ↗
Leadership
Pay as last reported
- Mr. Benoit VillersChairman of the Board, since 2023
- Mr. Jean-francois DoucetChief Executive Officer
- Ms. Valerie FiliatreDirector€117,824
- Mr. Jean-luc Souche FrancaisDirector€9,000
- Mr. Philippe DujardinIndependent Director€14,500
- Mr. Pierre Morgon FrenchIndependent Director€14,500
- Ms. Sylvie GuinardIndependent Director€13,500
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Amoeba SA boasts a robust market presence in its industry, with a strong brand reputation and a loyal customer base. This allows the company to maintain a competitive edge and attract new customers easily.
- The company has a diverse and innovative product portfolio, offering unique and cutting-edge solutions that cater to the ever-changing market demands. This enables Amoeba SA to stay ahead of its competitors and capitalize on emerging trends.
Weaknesses
- Amoeba SA heavily relies on a few key suppliers for its raw materials, which poses a potential risk in case of any disruptions in the supply chain. This vulnerability may lead to production delays or increased costs for the company.
- Although Amoeba SA has a strong presence in its domestic market, it faces challenges in expanding its operations globally. Limited international presence restricts the company's potential for growth and exposes it to potential risks from local market fluctuations.
Opportunities
- Amoeba SA has an opportunity to capitalize on the increasing demand for sustainable products. By developing and promoting eco-friendly solutions, the company can attract environmentally conscious customers and gain a competitive advantage in the market.
- The rapid advancement of technology provides Amoeba SA with opportunities to enhance its products and processes. By investing in research and development, the company can create innovative solutions, improve operational efficiency, and gain a larger market share.
Threats
- Amoeba SA operates in a highly competitive market, facing constant pressure from rival companies. This intensifies the need for continuous innovation, effective marketing strategies, and maintaining high product quality to stay ahead of the competition.
- Economic uncertainties, such as market fluctuations, inflation, and trade policies, pose a threat to Amoeba SA's operations. Abrupt changes in the economic landscape can affect consumer purchasing power, demand for the company's products, and overall profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.